AIST - Organization and Outline -

19/56

Life Science and BiotechnologyDevelopment of technologies to create advanced and comprehensive drugs and medical technologies to protect healthIn order to solve issues such as disease prevention, early treatment, and personalized medicine, we are developing regenerative-medicine technologies and advanced healthcare support technologies using cell-manipulation and biomaterial technologies, and an infrastructure for the development of medical equipment. For disease prevention and early diagnosis, we are developing technologies to characterize and analyze the functions of biomolecules. We are also developing high-efficiency drug discovery techniques to cut development costs without compromising safety through the amalgamation of information processing and bioanalysis. Development of technologies to achieve healthy lifeIn order to ensure a healthy life both mentally and physically, it is important to solve the issues of elderly care and maintenance and improvement of health, as well as mental issues associated with social anxiety. We are developing technologies to quantitatively evaluate mental and physical conditions, including stress, and to restore, maintain, and improve health through personalized medication and rehabilitation, with a view to developing technologies to facilitate healthy living.Development of technologies to efficiently manufacture high-quality substances using bioprocesses that help to reduce industrial environmental loadsWith a view to extending the range of application of bioprocesses (material production using microbes and enzymes) that provide much higher reaction selectivity than chemical processes and allow efficient production of high-value-added compounds, we are searching for microbial resources and useful genes and characterizing their functions. We are also developing high-efficiency biomanufacturing technologies, including technologies to improve the functions of biopolymers and improve and design bioprocesses, technologies to produce transgenic modified plants, and technologies to bring a closed system for transgenic plant production into practical use.【Outline of priority strategies】Noboru YumotoVice-PresidentDirector-GeneralIt is necessary to build a healthy longevity society where people can live their lives in a state of well-being and security, as well as a sustainable society with less burden on the environment. We are contributing to life innovation by developing new technologies to evaluate health and assisting in the creation of new medicines as well as in the maintenance, improvement, and recovery of health according to the individual’s condition. We are also contributing to green innovation by developing technologies to reduce environmental loads using bioprocesses.Toward a sustainable society in which people live a long life with health and vigorMasanao Oda Deputy Director-GeneralTEL : 029-862-6032 (from outside Japan: +81-29-862-6032)E-mail : life-liaison-ml@aist.go.jpTomohiro Tamura Director, Research Planning Office18Organization and Outline

※このページを正しく表示するにはFlashPlayer9以上が必要です